Korean journal of dermatology (대한피부과학회지)

Korean Dermatological Association (대한피부과학회)
권호 표지

Efficacy of 0.1% Tacrolimus Ointment in Korean Patients with Atopic Dermatitis

한국인 아토피 피부염 환자에서 0.1% tacrolimus 연고의 치료효과

Kim, Hye-One;Park, Chun-Wook;Lee, Cheol-Heon;Lee, Joung-Ok
김혜원;박천욱;이철헌;이정옥

  • Published : 20050300
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Hanifin JM. Atopic dermatitis: broadening the perspective. J Am Acad Dermatol. 2004;51 (Suppl 1):23-24 https://doi.org/10.1016/j.jaad.2004.01.010
  2. Guin JD. Complications of topical hydrocortisone. J Am Acad Dermatol 1981;4:417-422 https://doi.org/10.1016/S0190-9622(81)70040-9
  3. Graham-Brown R. Managing adults with atopic dermatitis. Dermatol Clin 1996;14:531-537 https://doi.org/10.1016/S0733-8635(05)70381-8
  4. Smith CH. New approaches to topical therapy. Clin Exp Dermatol 2000;25:567-574 https://doi.org/10.1046/j.1365-2230.2000.00706.x
  5. Nasr IS. Topical tacrolimus in dermatology. Clin Exp Dermatol 2000 ;25:250-254 https://doi.org/10.1046/j.1365-2230.2000.00628.x
  6. Gupta AK, Adamiak A, Chow M. Tacrolimus: A review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol 2002; 16:100-114 https://doi.org/10.1046/j.1468-3083.2002.00380.x
  7. Katoh N, Hirano S, Yasuno H, Kishimoto S. Effects of tacrolimus ointment on facial eruption, itch , and scratching in patients with atopic dermatitis. J Dermatol 2004;31:194-199
  8. Hanifin JM, Ling MR, Langley R, Breneman D, Rafal E. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001 ;44:S28-38 https://doi.org/10.1067/mjd.2001.109810
  9. Soter NA, Fleischer AB Jr, Webster GF, Monroe E, Lawrence I. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients : part II, safety. J Am Acad Dermatol 2001;44(Suppl 1):S39-46 https://doi.org/10.1067/mjd.2001.109817
  10. Kapp A, Allen BR, Reitamo S. Atopic dermatitis management with tacrolimus ointment ($Protopic^{ⓡ}$). J Dermatol Treat 2003;14:155-166
  11. Won CH, Seo PG, Park YM, Yang JM, Lee KH, Sung KJ et al. A multicenter trial of the efficacy and safety of 0.03% tacralimus ointment for atopic dermatitis in Korea. J Dermatol Treat 2004; 15:30-34 https://doi.org/10.1080/09546630310020812
  12. Choi WW, Seo PG, Kim KH. Tacrolimus ointment; An open study for effects on severe facial atopic dermatitis in Korean. Ann Dermatol 2002;14:195-199
  13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm vencrol (Stockh) 1980;92(Suppl): 44-47
  14. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 1989;144 (Suppi) :13-14
  15. Cherill R, Graeber M, Hanifin JM, Omoto M, Thurston M, Tofte S. Eczema area and severity index (EASI) : a new tool to evaluate atopic dermatitis J Eur Acad Dermatol Venereol 1998;11 (Suppl 2):48 https://doi.org/10.1111/j.1468-3083.1998.tb00953.x
  16. Toyoda M, Morahashi M. Morphological assessment of the effects of cyclosporin A on mast cell-nerve relationship in atopic dermatitis. Acta Derm Veneral (Stockh) 1998;78:321-325 https://doi.org/10.1080/000155598442962
  17. Fleischer AB Jr, Ling M, Eichenfield L, Satoi Y, Jaracz E, Rico MJ et al. Tacrolimus ointment for the treatment of atopic dermatitis is not associated with an increase in cutaneous infections. J Am Acad Dermatol 2002;47 :562-570 https://doi.org/10.1067/mjd.2002.124603
  18. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD et al. A short term trial of tacrolimus ointment for atopic dermatitis. New Eng J Med 1997;337:816-821 https://doi.org/10.1056/NEJM199709183371203
  19. Bork K, Brauninger W. Increasing indicence of eczema herpeticum; analysis of seventy-five cases. J Am Acad Dermatol 1988;19:1024-1029 https://doi.org/10.1016/S0190-9622(88)70267-4
  20. Stander S, Luger TA. Antipruritic effects of pimecrolimus and tacrolimus. Hautarzt. 2003;54:413-417